Nutrients· 2026Q1
Dried Blood Spot-Based Monitoring of Dietary Treatment in Children, Adolescents, and Young Adults with Inherited Disorders of Amino Acid Metabolism: A Four-Year Pilot Study
- 0citations
- Q1SCImago
- 2026year
Short summary
Home-collected dried blood spot (DBS) samples, analyzed via mass spectrometry, are a feasible method for monitoring dietary treatment in children and young adults with specific inherited amino acid metabolism disorders, showing utility particularly in maple syrup urine disease and glutaric aciduria type 1.
AI-generated from the title and abstract; the full text is not read.
Key points
- Dried blood spot (DBS) samples collected at home are a feasible alternative to venous blood for monitoring dietary treatment in inherited amino acid metabolism disorders.
- Mass spectrometry analysis of DBS samples successfully identified abnormal metabolite concentrations, guiding dietary interventions in conditions like maple syrup urine disease and glutaric aciduria type 1.
- Annual completion rates for planned DBS measurements ranged from 56.7% to 73.0% over four years.
- Routine monthly DBS monitoring provided limited additional clinical value for several of the studied disorders.
AI-generated from the title and abstract; the full text is not read.
Abstract
Background: Regular biochemical monitoring is essential for the safe and effective dietary treatment of inherited disorders of amino acid metabolism. However, conventional venous blood sampling may limit monitoring frequency and increase the burden on families. This study evaluated the feasibility and clinical usefulness of home-collected dried blood spot (DBS) samples analyzed using tandem mass spectrometry and additional chromatographic methods for dietary monitoring in inherited disorders of amino acid metabolism other than phenylketonuria. Methods: Between 2022 and 2025, children, adolescents, and young adults aged between 4 months and 20.5 years who were followed at a national metabolic center were monitored using DBS samples. The initial cohort included patients with maple syrup urine disease, tyrosinemia type III, homocystinuria, glutaric aciduria type 1, methylmalonic aciduria, isovaleric aciduria, argininosuccinic aciduria, methionine adenosyltransferase I/III deficiency, beta-ketothiolase deficiency, propionic aciduria, gyrate atrophy, and citrullinemia type 1. Disease-specific amino acids and metabolites were assessed to guide individualized dietary recommendations. Results: The number of monitored patients ranged from 24 to 40 per year. Overall annual completion rates of planned DBS measurements ranged from 56.7% to 73.0%, with additional clinically indicated samples collected in selected patients. DBS monitoring detected abnormal metabolite concentrations and supported dietary interventions, particularly in maple syrup urine disease, glutaric aciduria type 1, homocystinuria, tyrosinemia type III, and MAT I/III deficiency. In several other disorders, routine monthly DBS monitoring showed limited additional clinical value. Conclusions: DBS-based monitoring is a feasible approach that may support individualized dietary management in selected inherited disorders of amino acid metabolism, especially in early childhood and during periods of increased metabolic risk.
The authors' abstract, as published at the source. Nutrients, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Clinical Biochemistry
Clinical BiochemistryBiochemistry, Genetics and Molecular Biology